.
MergerLinks Header Logo

New Deal


Announced

Completed

ArisGlobal completed the acquisition of Amplexor Life Sciences from Acolad.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

language services

Digital Services

digital content services

Majority

Private

Single Bidder

Friendly

Cross Border

Acquisition

Completed

Slovenia

Synopsis

Edit

ArisGlobal, a provider of life sciences software, completed the acquisition of Amplexor Life Sciences, a provider of regulatory, quality, and safety software solutions, from Acolad, a provider of a full suite of content and language solutions, services and technology. Financial terms were not disclosed. "For many years, ArisGlobal has been focused on building a regulatory platform that provides a market-leading, comprehensive set of products and streamlines processes supporting collaboration across distributed teams while adhering to extensive and evolving global regulatory requirements. By combining our core functionalities, we are elevating our end-to-end Regulatory capabilities to enhance our customers' journey," Mike Gordon, ArisGlobal CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US